"As US biotech companies, how do we continue to differentiate and create novel breakthrough assets? I think it's leveraging AI." Sean McClain, founder and CEO of Absci, and Christian Stegmann, SVP of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results